For so long the US healthcare system was built around the provider, with appointments and services set by the provider (along with insurance reimbursement systems).
In this week’s pharmaphorum digital health round-up we look at Akili’s therapeutic video game, the unveiling of next-gen medical imaging tech by NVIDIA, a new blockcha
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh